6,000 Pharmaceutical Scientists Convene November 15-19 In San...( Newest Dr...)

6,000 Pharmaceutical Scientists Convene November 15-19 In San Francisco

Newest Drug Discoveries And Pharmaceutical Research To Be Unveiled At American Association Of Pharmaceutical Scientists (AAPS) Annual Meeting In San Francisco On November 15-19

Alexandria, VA -- November 2, 1998 -- Six thousand of the world's premier pharmaceutical researchers will gather in San Francisco on November 15-19 to discuss the latest scientific research and medical advances of 1998. A small sampling of the breakthroughs, presented for the first time at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, are listed below:

Sound-Alike Drugs Cause Potentially Dangerous Prescription Errors -- Nicoderm...Nitroderm; Xanax...Zantac: According to the FDA, look-alike and sound-alike drugs are causing roughly one death a day. Further, one out of every four reported prescription errors made by a pharmacist is due to name confusion. Pharmaceutical scientists are now studying this critical nomenclature issue and determining how to keep drugs with confusing names from reaching the market. Several of their recommendations to curb the probability of mistakes are currently being reviewed by the FDA.

Impact of High Altitude on Drug Efficacy -- Those who enjoy traveling to exotic locations, beware. The latest research shows that staying at high altitudes for more than 24 hours can alter the effect of drugs like DemerolTM, LithiumTM and even widely-used high altitude sickness medications like acetazolamide. How can skiers, hikers and tourists determine if their med
'"/>

Contact: Amy Miller
miller@aaps.org
703-518-8417
American Association of Pharmaceutical Scientists
27-Oct-1998

Page: 1 2 3
Related medicine news :

1. Emergency clopidogrel could save thousands of lives46,000-patient heart attack trial results
2. Over 6,000 Technical Presentations Will Reveal New Findings At National Chemists Meeting In Boston, August 23 - 27
3. Pharmaceutical marketing tactics hold little sway with prescribing physicians
4. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
5. Pharmaceutical Achievers
6. Pharmaceutical industry still failing health needs of less-developed countries
7. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
8. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
9. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
10. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
11. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years

Post Your Comments:

(Date:6/19/2013)... June 19 online edition of the journal Nature ... University of California, San Diego School of Medicine visually ... cardiac regeneration occurs in zebrafish after cardiac ventricular injury. ... in the heart are more plastic, or capable of ... More importantly, the research reveals a novel potential source ...

(Date:6/19/2013)... understanding of the genetic process that can lead to ... lesions for some women, and also raises a warning ... cases suggesting they could actually trigger the cancer ... a clearer picture of the chromosomal and genetic changes ... to chronic infection and, in less than 1 percent ...

(Date:6/19/2013)... significant disparities between minority and white clients in ... Moreover, these disparities vary widely from state to ... most states there,s something amiss," says Stephan Arndt, ... are strong racial and ethnic disparities for people ... programs successfully, and those disparities are something we ...

(Date:6/19/2013)... In early April, senior leaders from medical, law ... to discuss one question: how can first responders improve ... The preliminary results of this discussion are now available ... Hartford Consensus ," a concept paper published in the ... Trauma and Acute Care Surgery , official publication ...

(Date:6/19/2013)... Nearly 70 percent of Americans are on at ... take two, Mayo Clinic researchers say. Antibiotics, antidepressants ... study found. Twenty percent of patients are on ... findings, published online in the journal Mayo ... and video of Dr. Jennifer St. Sauver talking ...

Breaking Medicine News(10 mins):Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2 Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2 Health News:States vary widely on success rates for minorities in drug treatment programs 2 Health News:States vary widely on success rates for minorities in drug treatment programs 3 Health News:Hartford consensus aims to improve survival after mass shootings 2 Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2

[0] Fate of the heart: Researchers track cellular events leading to cardiac regeneration [0] Genetics of cervical cancer raise concern about antiviral therapy in some cases [0] States vary widely on success rates for minorities in drug treatment programs [0] Hartford consensus aims to improve survival after mass shootings [0] Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds

(Date:6/19/2013)... -- A decade-long JDRF-funded study led by the Institute ... Germany , is providing a deeper understanding of ... type 1 diabetes (T1D), highlighting the importance of pre-diabetes ... "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression ... The Journal of the American Medical Association . ...

(Date:6/19/2013)... 19, 2013 Finesse Solutions, Inc, a manufacturer ... process applications, announced the launch of its new ... culture and fermentation. The 3L glass vessels are ... Finesse bioreactors and are designed to optimize yield ... fully compatible with all Finesse G3Lab controllers, and ...

(Date:6/19/2013)... 19, 2013 Decision Resources, one of the ... and healthcare issues, finds that, for the treatment ... and European rheumatologists cite a therapy,s induction of ... influences their prescribing decisions. Over 60 percent and ... rank the percentage of patients achieving remission at ...

Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2 New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3 Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2 U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2

[0] New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development [0] Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation [0] U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis

Cached News:

Simple intervention improves quality of dialysis treatment Statin drugs may lower risk of Alzheimers Though rare, victims of lightning strike may suffer Stem cell transplants may be effective for MS patients

VCU study: Low-dose oral contraceptives may increase risk for heart attack or stroke Bedsharing, even with non-smoking parents, may increase risk of SIDS Computers: Poor placement does not compute in medical exam rooms Mood lighting: Penn researchers determine role of serotonin in modulating circadian rhythm